Quantcast

Latest Morphinans Stories

2014-05-07 08:33:35

CUPERTINO, Calif., May 7, 2014 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that James E. Brown, President and CEO of DURECT Corporation, will be an industry speaker at the Bay Area Prescription Drug Abuse Summit on May 7, 2014 in San Francisco. The summit is an effort to bring together senior policymakers, medical professionals, educators, local, state and federal law enforcement and the community to seek solutions to this problem and to raise awareness of the...

2014-05-06 23:17:29

Passages Malibu CEO comments on enhanced access to treatment in the US. Malibu, CA (PRWEB) May 06, 2014 On April 3rd, the Food and Drug Administration announced its approval of Evzio, an antidote to opiate overdose. The medication was designed to be easily administered by family members or caregivers via an auto-injector. Evzio contains naloxone, which has proven valuable in the fight to save people from heroin and opiate overdose. An overdose of opiates is generally characterized by...

2014-05-06 23:15:14

With heroin abuse an urgent health crisis that has Connecticut in its grip, the new detoxification program, Mountainside Detox, is being created to alleviate the mounting need for additional treatment services in the state starting in late spring. Canaan, CT (PRWEB) May 06, 2014 Heroin abuse is an urgent health crisis that has Connecticut in its grip, with heroin addiction currently ranking second behind alcohol as the reason people seek substance abuse treatment. Mountainside treatment...

2014-05-06 16:32:33

ALISO VIEJO, Calif., May 6, 2014 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today reported financial results for the three and six months ended March 31, 2014. http://photos.prnewswire.com/prnvar/20130207/LA55901LOGO Quarterly Financial Highlights -- Total company net revenues of $26.9 million -- Net NUEDEXTA® sales of $24.4 million -- Cash, cash equivalents, and restricted investments of $56.5 million as of March 31, 2014. "We are extremely pleased...

2014-04-30 23:21:39

New hydrocodone painkiller could come with an increased risk of addiction. Fort Lauderdale, Fla. (PRWEB) April 30, 2014 A brand-new painkiller has been released, and it could pose a very serious threat to the public. Zohydro is the first painkiller that is made up only of hydrocodone, and available dosage amounts go as high as 50 milligrams. This is five times as much as comparable drugs. Destination Hope's Florida drug rehab is concerned that a lack of education and easy access to...

2014-04-30 12:30:02

Patent Protection for KP511 Extends KemPharm's Intellectual Property Estate for Leading Franchise of Abuse-Deterrent Opioid Medications CORALVILLE, Iowa, April 30, 2014 /PRNewswire/ -- KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its patent application titled, "Benzoic...

2014-04-30 08:33:23

Data from Clinical Drug-liking Studies Also to be Presented at APS Today STAMFORD, Conn., April 30, 2014 /PRNewswire/ -- Purdue Pharma L.P. announced that it has filed a New Drug Application (NDA) with the U.S. Food & Drug Administration (FDA) seeking authorization to market a once-daily, single-entity hydrocodone bitartrate tablet (HYD). This investigational pain medication was formulated to incorporate abuse-deterrent properties designed to make the product more difficult to manipulate...

2014-04-30 08:32:53

GeneSight® Analgesic Test Now Includes 22 Opioids and Non-opioid Pain Medications MASON, Ohio, April 30, 2014 /PRNewswire/ -- Assurex Health, Inc. today announced a significant expansion of its GeneSight® Analgesic test. The expanded test gives clinicians a multi-gene pharmacogenomics tool to guide medication decisions for patients with acute or chronic pain using patients' own genetic profiles to help determine their potential response to 22 medications across four relevant...

2014-04-29 20:26:48

LONDON, April 29, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: The World Market for Pain Management Drugs and Deviceshttp://www.reportbuyer.com/pharma_healthcare/healthcare/world_market_pain_management_drugs_devices.html This study encompasses a wide variety of products that treat and ease pain. The field of pain management is currently experiencing a busy and interesting period; and as a result, the range of therapeutic options available to...

2014-04-29 12:33:30

STAMFORD, Conn., April 29, 2014 /PRNewswire/ -- Purdue Pharma L.P. will present results from a number of research studies at the American Pain Society (APS) 33(rd) Annual Scientific Meeting, April 30-May 3, 2014, in Tampa, Fla. Following is a schedule of select poster presentations: Authors Date / Time Title...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related